Compounds > ifosfamide
Page last updated: 2024-10-29

ifosfamide and Leukoencephalopathy Syndrome, Posterior

ifosfamide has been researched along with Leukoencephalopathy Syndrome, Posterior in 2 studies

Research Excerpts

ExcerptRelevanceReference
"We present a 56-year-old woman who received chemotherapy for relapsed diffuse large B-cell lymphoma and developed posterior reversible encephalopathy syndrome (PRES) with generalized seizures 27 days after treatment with rituximab, ifosfamide, carboplatin and etoposide (R-ICE)."3.81[Malignant lymphoma complicated with posterior reversible encephalopathy]. ( Hansen, PB; Thomsen, RH; Zakarian, K, 2015)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Peddi, PF1
Peddi, S1
Santos, ES1
Morgensztern, D1
Thomsen, RH1
Zakarian, K1
Hansen, PB1

Reviews

1 review available for ifosfamide and Leukoencephalopathy Syndrome, Posterior

ArticleYear
Central nervous system toxicities of chemotherapeutic agents.
    Expert review of anticancer therapy, 2014, Volume: 14, Issue:7

    Topics: Antineoplastic Agents; Central Nervous System Diseases; Cisplatin; Cytarabine; Fluorouracil; Humans;

2014

Other Studies

1 other study available for ifosfamide and Leukoencephalopathy Syndrome, Posterior

ArticleYear
[Malignant lymphoma complicated with posterior reversible encephalopathy].
    Ugeskrift for laeger, 2015, Sep-07, Volume: 177, Issue:37

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Ifosfamide;

2015